Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Elixir Department: SOP for Statistical Trending of IPC Data – V 2.0

Posted on By

Elixir Department: SOP for Statistical Trending of IPC Data – V 2.0

Standard Operating Procedure for Statistical Trending of In-Process Control (IPC) Data

Department Elixir Department
SOP No. SOP/ELX/210/2025
Supersedes SOP/ELX/210/2022
Page No. Page 1 of 8
Issue Date 11/04/2025
Effective Date 15/04/2025
Review Date 11/04/2026

1. Purpose

To define a systematic approach for the statistical analysis and trending of In-Process Control (IPC) data generated during elixir manufacturing. The objective is to detect variability, identify trends, and ensure process consistency and continuous improvement.

2. Scope

This SOP applies to all IPC data collected during the production of elixirs, including but not limited to pH, weight per mL, API assay, clarity, and viscosity. It includes manual and electronic data trending, review, and reporting practices.

3. Responsibilities

  • QC Analyst:
    • Record IPC data accurately and maintain relevant trend sheets or databases.
  • QA Officer:
    • Review statistical trend reports and investigate deviations or unusual shifts.
  • Data Analyst / QA Executive:
    • Compile, analyze, and interpret monthly IPC data for trend evaluation.
See also  Elixir Department: SOP for Sampling from Storage Tank - V 2.0

4. Accountability

The QA Head is accountable for overseeing the IPC data trending process and implementing corrective actions where necessary. The QC Head is

responsible for ensuring timely and accurate data capture.

5. Procedure

5.1 Data Collection

  1. Collect IPC data from:
    • Batch Manufacturing Records (BMRs)
    • IPC logbooks and electronic LIMS systems (if applicable)
  2. Transfer IPC parameters into standardized data entry templates (Annexure-1).
  3. Ensure data entry includes:
    • Batch number
    • Date
    • IPC parameter
    • Observed value

5.2 Statistical Analysis

  1. Use Microsoft Excel or validated statistical software for plotting and analysis.
  2. Generate the following for each parameter:
    • Mean, standard deviation
    • Upper and lower control limits (UCL & LCL)
    • Control charts (X-bar and R charts, if required)
  3. Assess for:
    • Shifts or trends
    • Outliers
    • Process drift or variability

5.3 Frequency of Trending

  1. Perform trending:
    • Monthly – compiled report
    • Quarterly – management summary
    • Annually – trend summary for Product Quality Review (PQR)
See also  Elixir Department: SOP for Limit Test for Chloride and Sulfates - V 2.0

5.4 Review and Reporting

  1. QA shall review trend charts monthly for any excursions.
  2. Any deviation beyond control limits shall be treated as a potential process deviation and reviewed with Production and QC.
  3. Prepare IPC Trending Report (Annexure-2) and submit to QA Head for review and signature.

5.5 Corrective and Preventive Action (CAPA)

  1. Initiate CAPA if:
    • Repeated outliers are observed
    • Control limits are consistently approached
    • Unexpected shifts are seen in trends
  2. Document CAPA in the CAPA register and link to trend reports.

6. Abbreviations

  • IPC: In-Process Control
  • SOP: Standard Operating Procedure
  • QA: Quality Assurance
  • QC: Quality Control
  • BMR: Batch Manufacturing Record
  • UCL: Upper Control Limit
  • LCL: Lower Control Limit
  • CAPA: Corrective and Preventive Action

7. Documents

  1. IPC Data Entry Template (Annexure-1)
  2. IPC Trending Report (Annexure-2)
  3. CAPA Register (if applicable)
See also  Elixir Department: SOP for Cleaning and Sanitization of Storage Vessels - V 2.0

8. References

  • ICH Q10 – Pharmaceutical Quality System
  • 21 CFR Part 211.180 – Records and Reports
  • WHO TRS 986 – GMP Guidelines

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: IPC Data Entry Template

Batch No. Parameter Result Test Date Specification Initials
ELX-0425-028 pH 6.8 11/04/2025 6.5 – 7.5 Rajesh Kumar

Annexure-2: IPC Trending Report

Month Parameter Mean Std. Deviation UCL LCL Remarks Reviewed By (QA)
March 2025 pH 6.82 0.09 7.00 6.60 Within Trend Sunita Reddy

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
01/01/2024 1.0 Initial Release New SOP QA Head
11/04/2025 2.0 Enhanced to include CAPA linkage and trend report formats Process Control Improvement QA Head
Elixers V 2.0 Tags:Elixir colorants, Elixir dosage form, Elixir filtration techniques, Elixir flavoring agents, Elixir formulation, Elixir GMP compliance, Elixir manufacturing process, Elixir manufacturing SOPs, Elixir packaging requirements, Elixir pharmacopoeial standards, Elixir preparation methods, Elixir preservatives, Elixir production equipment, Elixir quality control, Elixir regulatory guidelines, Elixir shelf life, Elixir stability testing, Elixir sterilization methods, Elixir storage conditions, Elixir sweetening agents, Elixir viscosity modifiers, Hydroalcoholic solutions, Medicated elixirs, Non-medicated elixirs, Pharmaceutical elixirs

Post navigation

Previous Post: Analytical Method Development: SOP for Tablet Hardness Impact on Dissolution – V 2.0
Next Post: Best Practices for Documenting SOP Changes

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version